Literature DB >> 17557926

Genetic screening for pheochromocytoma: should SDHC gene analysis be included?

M Mannelli1, T Ercolino, V Giachè, L Simi, C Cirami, G Parenti.   

Abstract

PGL3 syndrome is caused by mutations in the SDHC gene. At present, only a few families affected by SDHC mutations have been reported in the literature and in each of them the clinical presentation was characterised by paragangliomas located only in the head and neck regions. No evidence of thoracic or abdominal catecholamine-secreting chromaffin tumours has been reported to date. We report the case of a 15-year-old girl with hypertension and a norepinephrine-secreting abdominal paraganglioma who was found to harbour a novel nonsense SDHC mutation, demonstrating that the clinical presentation of PGL3 syndrome can be more diverse than expected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557926      PMCID: PMC2597951          DOI: 10.1136/jmg.2007.051045

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Authors:  D Astuti; F Latif; A Dallol; P L Dahia; F Douglas; E George; F Sköldberg; E S Husebye; C Eng; E R Maher
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

3.  Germ-line mutations in nonsyndromic pheochromocytoma.

Authors:  Hartmut P H Neumann; Birke Bausch; Sarah R McWhinney; Bernhard U Bender; Oliver Gimm; Gerlind Franke; Joerg Schipper; Joachim Klisch; Carsten Altehoefer; Klaus Zerres; Andrzej Januszewicz; Charis Eng; Wendy M Smith; Robin Munk; Tanja Manz; Sven Glaesker; Thomas W Apel; Markus Treier; Martin Reineke; Martin K Walz; Cuong Hoang-Vu; Michael Brauckhoff; Andreas Klein-Franke; Peter Klose; Heinrich Schmidt; Margarete Maier-Woelfle; Mariola Peçzkowska; Cesary Szmigielski; Charis Eng
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

4.  Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.

Authors:  Francesca Schiavi; Carsten C Boedeker; Birke Bausch; Mariola Peçzkowska; Clara Fuentes Gomez; Thomas Strassburg; Christian Pawlu; Mary Buchta; Maren Salzmann; Michael M Hoffmann; Ansgar Berlis; Ingo Brink; Markus Cybulla; Mihaela Muresan; Martin A Walter; Flavio Forrer; Matti Välimäki; Andrzej Kawecki; Zbigniew Szutkowski; Jörg Schipper; Martin K Walz; Pascal Pigny; Catherine Bauters; Joan E Willet-Brozick; Bora E Baysal; Andrzej Januszewicz; Charis Eng; Giuseppe Opocher; Hartmut P H Neumann
Journal:  JAMA       Date:  2005-10-26       Impact factor: 56.272

5.  Phaeochromocytoma, new genes and screening strategies.

Authors:  Anne-Paule Gimenez-Roqueplo; Hendrik Lehnert; Massimo Mannelli; Hartmut Neumann; Giuseppe Opocher; Eamonn R Maher; Pierre-François Plouin
Journal:  Clin Endocrinol (Oxf)       Date:  2006-12       Impact factor: 3.478

6.  Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X.

Authors:  L Simi; R Sestini; P Ferruzzi; M S Gaglianò; F Gensini; M Mascalchi; L Guerrini; C Pratesi; P Pinzani; G Nesi; T Ercolino; M Genuardi; M Mannelli
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

  6 in total
  33 in total

1.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

Review 2.  Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

Authors:  P Björklund; K Pacak; J Crona
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

3.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

4.  Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Henri Timmers; Massimo Mannelli; Stefan K Grebe; Lorenz C Hofbauer; Stefan R Bornstein; Oliver Tiebel; Karen Adams; Gennady Bratslavsky; W Marston Linehan; Karel Pacak
Journal:  Clin Chem       Date:  2011-01-24       Impact factor: 8.327

Review 5.  SDH-related pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Kathryn S King; Karel Pacak
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

6.  Bronchial Paraganglioma with SDHB Deficiency.

Authors:  M R Ghigna; P Dorfmuller; A Crutu; E Fadel; V Thomas de Montpréville
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

7.  Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.

Authors:  Monica L Marvin; Carol R Bradford; James C Sisson; Stephen B Gruber
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

8.  Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Authors:  Mariola Peczkowska; Zoran Erlic; Michael M Hoffmann; Mariusz Furmanek; Jaroslaw Cwikla; Agata Kubaszek; Aleksander Prejbisz; Zbigniew Szutkowski; Andrzej Kawecki; Krzysztof Chojnowski; Anna Lewczuk; Mieczyslaw Litwin; Witold Szyfter; Martin A Walter; Maren Sullivan; Charis Eng; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

9.  The approach to the patient with paraganglioma.

Authors:  Hartmut P H Neumann; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2009-08       Impact factor: 5.958

10.  The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.

Authors:  Jean-Pierre Bayley; Anneliese E M Grimbergen; Patrick A van Bunderen; Michiel van der Wielen; Henricus P Kunst; Jacques W Lenders; Jeroen C Jansen; Robin P F Dullaart; Peter Devilee; Eleonora P Corssmit; Annette H Vriends; Monique Losekoot; Marjan M Weiss
Journal:  BMC Med Genet       Date:  2009-04-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.